SCHEMBL7227930

SCHEMBL7227930

CCCn1cnc2c(NCc3cccc(OCC)c3OCC)nc(Cl)nc21

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 3/20 0.52
YTHDC1 Q96MU7 4/20 0.48
HDAC1 Q13547 3/20 0.47
CDK1 P06493 1/20 0.46
MAPT P10636 1/20 0.46
ADORA2A P29274 2/20 0.43
PDE1A P54750 1/20 0.43
PDE1B Q01064 1/20 0.43
PDE1C Q14123 1/20 0.43
PPARG P37231 1/20 0.43
CCNE2 O96020 1/20 0.43
CCNE1 P24864 1/20 0.43
CDK2 P24941 1/20 0.43
HDAC2 Q92769 2/20 0.43
CTSL P07711 2/20 0.43
TMIGD3 P0DMS9 1/20 0.43
ADORA1 P30542 1/20 0.43
HDAC3 O15379 1/20 0.42
HDAC4 P56524 1/20 0.42
HDAC7 Q8WUI4 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6941325 0.88 YTHDC1 (0.56) ADORA3YTHDC1HDAC1CDK1MAPT
SCHEMBL7227927 0.84 CDK1 (0.61) ADORA3CDK1MAPTCCNE2CCNE1
SCHEMBL6817859 0.78 CDK1 (0.74) YTHDC1HDAC1CDK1ADORA2ACCNE2
SCHEMBL6152650 0.76 CTSL (0.69) HDAC1CDK1ADORA2ACCNE2CCNE1
SCHEMBL786378 0.75 YTHDC1 (0.57) ADORA3YTHDC1CDK1MAPTADORA2A
SCHEMBL6820865 0.75 PPARG (0.65) ADORA3ADORA2APPARGADORA1
SCHEMBL6944109 0.74 CCNE2 (0.76) YTHDC1HDAC1CDK1ADORA2ACCNE2
SCHEMBL17628578 0.74 CDK1 (0.65) YTHDC1HDAC1CDK1ADORA2ACCNE2
SCHEMBL6945059 0.74 CCNE2 (0.57) YTHDC1HDAC1CDK1ADORA2ACCNE2
SCHEMBL17639878 0.73 PDE2A (0.58) HDAC1CDK1ADORA2APPARGCCNE2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6642231-B2 Antineoplastic agents, treatment for neuronal injury and degeneration AVENTIS PHARMACEUTICALS INC. 2003-11-04 US disclosed